19th November, 2021
The pandemic has fuelled investor interest in biotech, life sciences and drug discovery with state-owned investors ploughing more than US$5.5 billion into the space so far this year, mostly in the form of venture capital for startups – an increase of 53% over the whole of 2020.
Subscriber Post
1st September, 2021
On August 3, Alaska PFC reported its best annual performance ever, with a 29.7% return, and an all-time peak AuM of US$ 81.1 billion. A month before that, it had unveiled its strategy up to June 2025, when it expects private markets to rise to 40% of its portfolio. We had the immense pleasure of talking with Ms. Angela Rodell, who on October 1 will stand as the world’s only female CEO of a SWF.
Subscriber Post
27th August, 2021
Recent annual returns by state-owned investors have demonstrated that the rally in public equities has boosted portfolios, but long-term returns suggest private markets generate stronger yield.
Subscriber Post
9th August, 2021
Last week, United States’ largest Sovereign Wealth Fund, the Alaska Permanent Fund Corporation (APFC) released its results for the year ending on June 30, 2021 (FY21) and gave a clue on its strategy to FY25.
Subscriber Post
22nd March, 2021
State-Owned Investors have still a long way to go when it comes to diversity and inclusion.
Subscriber Post
13th January, 2021
The first month of 2021 is turning out to be a bumper month for investment by state-owned investors with the volume and value of transactions set to rival the busiest months of 2020 - and potentially see the return of activity to pre-pandemic norms.
Subscriber Post